PharmSource is pleased to present our special 2015 INTERPHEX edition of Bio/Pharmaceutical Outsourcing Report. This monthly publication, brought to you by PharmSource’s experts, keeps you on top of the latest industry news, with analysis on its impact for the industry and on your business – critical information for helping you navigate in the contract services arena.

Bio/Pharmaceutical Outsourcing Report is just one of the great resources our STRATEGIC ADVANTAGE subscribers receive.
 
 

To receive a complimentary PDF copy of this special edition, please fill out this form:

Table of Contents

Commercial Dose Manufacturing and Packaging
• Aenova Expands Injectables Capacity, Consolidates Network

Side Effects

Commercial Dose Manufacturing and Packaging in Brief

Latest PharmSource Trend Reports
• CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance
• Catching a Wave: How Much Will CMOs Benefit From Biosimilars?
• Opportunity Knocks: In-Licensed Drug Products Can Signal Outsourcing Opportunity
• CDMO and CRO Outlook: Robust Market Conditions Augur Growth

Clinical Dose Manufacturing and Packaging
• Catalent Expands Clinical Storage and 4 Packaging Capacity at German, UK 4 Facilities

Clinical Dose Manufacturing and Packaging in Brief

API — Large Molecule
• WuXi Doubles Down on Cell Therapy

API — Large Molecule in Brief

API — Small Molecule in Brief

Analytical Services

Business Conditions
• Flood of Money Buoys Service Providers

About PharmSource